Question 1

Does Jane Street Group own CNTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Jane Street Group holds 645,209 shares of CNTX (Context Therapeutics), worth $357,382.

Question 2

How many shares of CNTX does Jane Street Group own?

Accepted Answer

As of its Q2 2026 13F, Jane Street Group holds 645,209 shares of CNTX (Context Therapeutics).

Question 3

What is Jane Street Group's CNTX position worth?

Accepted Answer

As of its Q2 2026 13F, Jane Street Group's CNTX position is worth $357,382.

Question 4

Is Jane Street Group buying or selling CNTX?

Accepted Answer

In Q2 2026, Jane Street Group increased its CNTX position by 208,278 shares (+47.7%).

Question 5

When did Jane Street Group first buy CNTX?

Accepted Answer

Jane Street Group first reported CNTX in its Q3 2022 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	645,209	+47.7%	$357,382	0.0%	$0.55	22
2026-Q1	New	436,931	-	$1.1M	0.0%	$2.38	35
2025-Q1	Exited	0	-100.0%	$0	0.0%	$0.65	0
2024-Q4	New	27,395	-	$28,765	0.0%	$1.06	30
2023-Q1	Exited	0	-100.0%	$0	0.0%	$0.58	0
2022-Q4	Decreased	19,827	-72.5%	$12,921	0.0%	$0.65	0
2022-Q3	New	72,060	-	$80,000	0.0%	$1.11	33

CNTX7 quarters

CNTX
7 quarters